LimaCorporate announced that Luigi Ferrari, Chief Executive Officer, will be stepping down from the role of CEO to pursue new activities outside of the organization. Mr. Ferrari has led the organization for almost ten years, and his oversight saw the opening of the ProMade Point of Care for Complex Joint Reconstruction, in collaboration with the Hospital for Special Surgery in New York City.
Mr. Ferrari will remain with LimaCorporate as a Senior Advisor to the Advisory Board and to assist with the transition to new leadership. He will also retain an equity stake in the company.
Emmanuel Bonhomme, President Europe, Middle East and Africa at LimaCorporate, will act as interim CEO, while a selection process to appoint a new leader has been initiated.
Michel Orsinger, Chairperson of the LimaCorporate Advisory Board, said, "On behalf of the Advisory Board, I would like to thank Luigi for his work and dedication over these past years. Luigi has contributed substantially to our growth, overseeing our successful expansion into new international markets and the launch of many of our industry-leading product innovations, including establishing unique access to 3D printed custom implants to advance patient care and developing LimaCorporate's Smart SPACE digital ecosystem. I'm pleased that he will remain with us as an Advisor as we transition to new leadership and enter the next phase of our growth."
Emmanuel Bonhomme joined the LimaCorporate Management Team in 2018. As President of EMEA, he is responsible for LimaCorporate's largest geographic market, including full P&L responsibility, sales and investment management, and development for the region. In this role, he has overseen important development initiatives to strengthen LimaCorporate's market presence, leading to the region becoming the best performing area in 2021, with strong double-digit growth in revenues and profitability even throughout the pandemic. Prior to LimaCorporate, Mr. Bonhomme spent more than 25 years in executive roles at leading pharmaceutical and medical device companies, including 16 years in the orthopedic industry.